PL
Pliant Therapeutics, Inc.
PLRX · NASDAQ
$1.17 +2.63% (+$0.03)
1M +6.36%
Market Cap $72.4M
P/E Ratio -
Div. Yield -
ROE 53.22%
Bulios Fair Price
$1.07
8.5% downside
Trenutna cena
$1.17
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PLRX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.49x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 16.69%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 48.60%
ROIC 55.49%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -93.97x
Debt/Equity 0.20x
Current ratio 9.90x
Stability
50 /100
Moderate Profitable years 0
Beta 1.28x
EPS volatility 28.20%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PLRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bernard Coulie
Employees
49
Headquarters
South San Francisco
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report